CY1112438T1 - Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινη - Google Patents
Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινηInfo
- Publication number
- CY1112438T1 CY1112438T1 CY20111100452T CY111100452T CY1112438T1 CY 1112438 T1 CY1112438 T1 CY 1112438T1 CY 20111100452 T CY20111100452 T CY 20111100452T CY 111100452 T CY111100452 T CY 111100452T CY 1112438 T1 CY1112438 T1 CY 1112438T1
- Authority
- CY
- Cyprus
- Prior art keywords
- acute renal
- soluble
- thrombodouline
- treatment
- renal deficiency
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72637605P | 2005-10-13 | 2005-10-13 | |
| EP06825898A EP1948216B1 (en) | 2005-10-13 | 2006-10-12 | Treatment of acute renal failure with soluble thrombomodulin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1112438T1 true CY1112438T1 (el) | 2015-12-09 |
Family
ID=37670944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100452T CY1112438T1 (el) | 2005-10-13 | 2011-05-13 | Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινη |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080255047A1 (enExample) |
| EP (1) | EP1948216B1 (enExample) |
| JP (1) | JP5405829B2 (enExample) |
| AT (1) | ATE503489T1 (enExample) |
| CA (1) | CA2625888C (enExample) |
| CY (1) | CY1112438T1 (enExample) |
| DE (1) | DE602006021048D1 (enExample) |
| DK (1) | DK1948216T3 (enExample) |
| ES (1) | ES2360610T3 (enExample) |
| PL (1) | PL1948216T3 (enExample) |
| PT (1) | PT1948216E (enExample) |
| SI (1) | SI1948216T1 (enExample) |
| WO (1) | WO2007047430A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8076298B2 (en) | 2006-12-12 | 2011-12-13 | Eli Lilly And Company | Treating acute renal failure with soluble thrombomodulin variants |
| BRPI0922033A2 (pt) * | 2008-11-12 | 2015-12-15 | Lilly Co Eli | composições e métodos de uso de variantes de trombomodulina |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2022713A1 (en) * | 1989-08-11 | 1991-02-12 | Nils U. Bang | Human thrombomodulin derivatives |
| CA2129370A1 (en) * | 1992-02-05 | 1993-08-19 | David Richard Light | Protease-resistant thrombomodulin analogs |
| ATE249234T1 (de) * | 1993-12-17 | 2003-09-15 | Mochida Pharm Co Ltd | Lösliches thrombomodulin enthaltende zubereitung |
| US20050106124A1 (en) * | 2003-02-25 | 2005-05-19 | Sehgal Lakshman R. | Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
-
2006
- 2006-10-12 US US12/088,564 patent/US20080255047A1/en not_active Abandoned
- 2006-10-12 JP JP2008535706A patent/JP5405829B2/ja not_active Expired - Fee Related
- 2006-10-12 CA CA2625888A patent/CA2625888C/en not_active Expired - Fee Related
- 2006-10-12 WO PCT/US2006/040069 patent/WO2007047430A2/en not_active Ceased
- 2006-10-12 EP EP06825898A patent/EP1948216B1/en not_active Not-in-force
- 2006-10-12 DK DK06825898.7T patent/DK1948216T3/da active
- 2006-10-12 DE DE602006021048T patent/DE602006021048D1/de active Active
- 2006-10-12 ES ES06825898T patent/ES2360610T3/es active Active
- 2006-10-12 PT PT06825898T patent/PT1948216E/pt unknown
- 2006-10-12 PL PL06825898T patent/PL1948216T3/pl unknown
- 2006-10-12 SI SI200631016T patent/SI1948216T1/sl unknown
- 2006-10-12 AT AT06825898T patent/ATE503489T1/de active
-
2011
- 2011-05-13 CY CY20111100452T patent/CY1112438T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1948216A2 (en) | 2008-07-30 |
| CA2625888C (en) | 2015-09-22 |
| WO2007047430A3 (en) | 2007-05-24 |
| ATE503489T1 (de) | 2011-04-15 |
| WO2007047430A2 (en) | 2007-04-26 |
| DE602006021048D1 (de) | 2011-05-12 |
| CA2625888A1 (en) | 2007-04-26 |
| WO2007047430A8 (en) | 2008-04-10 |
| EP1948216B1 (en) | 2011-03-30 |
| PL1948216T3 (pl) | 2011-10-31 |
| JP5405829B2 (ja) | 2014-02-05 |
| JP2009511597A (ja) | 2009-03-19 |
| ES2360610T3 (es) | 2011-06-07 |
| DK1948216T3 (da) | 2011-06-06 |
| PT1948216E (pt) | 2011-05-06 |
| US20080255047A1 (en) | 2008-10-16 |
| SI1948216T1 (sl) | 2011-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120961T1 (el) | Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος | |
| CY1120022T1 (el) | Θεραπεια παιδιατρικης οξειας λεμφοβλαστικης λευχαιμιας | |
| CL2016002589A1 (es) | Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348). | |
| ATE551996T1 (de) | Behandlung oder prävention von diabetes mit cannabidiol | |
| MX391921B (es) | Nepicastat para usarse en el tratamiento de dependencia | |
| CY1117312T1 (el) | Θεραπευτικη αγωγη συνουκλεϊνοπαθειων | |
| CY1114712T1 (el) | Υδατικες φαρμακευτικες συνθεσεις περιεχουσες συμπλοκα βορικου-πολυολης | |
| HRP20110969T1 (en) | Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure | |
| EA201001771A1 (ru) | Лечение релаксином одышки, ассоциированной с острой сердечной недостаточностью | |
| NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
| DK1809661T3 (da) | Humant interferon-beta-mutein | |
| ATE548035T1 (de) | Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat | |
| EP2754447A3 (en) | Treating acute renal failure with soluble thrombomodulin variants | |
| UA88165C2 (xx) | Застосування тризаміщених бензопіранонів$применение трехзамещенных бензопиранонов | |
| ITMI20040954A1 (it) | Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica | |
| EA200702201A1 (ru) | Рофлумиласт для лечения лёгочной гипертензии | |
| ATE503489T1 (de) | Behandlung von akutem nierenversagen mit löslichem thrombomodulin | |
| DK1880727T3 (da) | Topisk vaginal farmaceutiske sammensætninger | |
| DK1843771T3 (da) | Anvendelse af pyrimidylaminobenzamider til behandling af sygdomme, der responderer på modulation af Tie-2-kinase-aktiviteten | |
| TN2011000206A1 (en) | Compositions and methods of use soluble thrombomodulin variants | |
| TR201901012T4 (tr) | Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı. | |
| DE502006006241D1 (de) | Verwendung von amino substituierten benzimidazolen | |
| ATE465741T1 (de) | 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität | |
| ATE454144T1 (de) | Behandlung von malignen neoplasien | |
| EA200801023A1 (ru) | Применение фенофибрата или его производного для предотвращения диабетической ретинопатии |